Breaking News Instant updates and real-time market news.

ATVI

Activision Blizzard

$41.68

1.57 (3.91%)

06:53
02/13/19
02/13
06:53
02/13/19
06:53

Activision Blizzard price target lowered to $45 from $48 at MKM Partners

MKM Partners analyst Eric Handler lowered his price target on Activision Blizzard to $45 and kept his Neutral rating after its "lacking" Q4 revenue and disappointing FY19 outlook. The analyst notes that the company's non-development and administrative cost reductions, as well as elimination of underperforming title investment, are "severely needed", but sees the timeline on these revitalization efforts as unclear. Handler reduces his FY19 EPS view for Activision Blizzard to $2.16 from $2.40, adding that the uncertainty is also weighing on his outlook for FY20.

  • 14

    Feb

ATVI Activision Blizzard
$41.68

1.57 (3.91%)

02/11/19
BNCH
02/11/19
NO CHANGE
Target $68
BNCH
Buy
Activision Blizzard price target lowered to $68 ahead of earnings at Benchmark
Benchmark analyst Mike Hickey previewed Activision Blizzard's Q4 results, stating that he remains cautious about near-term growth expectations given the uncertainty he sees around mobile and advertising performance contributions. The company's "clandestine restructuring" continues, said Hickey. The Fly notes that late last week Bloomberg cited people familiar with the matter in anticipating Activision Blizzard will announce layoffs Tuesday as part of the company's restructuring intended to centralize some of its functions. Hickey lowered his price target on Activision Blizzard shares to $68 from $87 ahead of the company's report but keeps a Buy rating, citing his view of its strong medium-term growth opportunity.
02/13/19
PIPR
02/13/19
NO CHANGE
Target $52
PIPR
Overweight
Activision target lowered to $52 after 'year to forget' at Piper Jaffray
Activision Blizzard's 2018 "was a year to forget" and 2019 is about re-balancing resources to focus on areas of potential growth, Piper Jaffray analyst Michael Olson tells investors in a post-earnings research note. The company posted Q4 revenue below and earnings in-line with consensus, while its 2019 guidance is below the Street, as expected, adds the analyst. Olson maintains an Overweight rating on Activision Blizzard and lowered his price target for the shares to $52 from $55.
02/13/19
RHCO
02/13/19
NO CHANGE
Target $49
RHCO
Buy
Activision Blizzard price target lowered to $49 from $54 at SunTrust
SunTrust analyst Matthew Thornton lowered his price target on Activision Blizzard (ATVI) to $49, saying the company's reported quarter and guidance were "clearly challenged", with added risk coming from the rising popularity of Electronic Arts' (EA) Apex Legends. The analyst also keeps his Buy rating on the stock, noting that some of its uncertainty has been removed while the management is increasing development investment to accelerate new content. Thornton lowers his FY19 and FY20 EPS by 42c and 43c to $2.25 and $2.50 respectively, adding that his new valuation multiples are in in with historical average and may prove conservative.
02/13/19
JPMS
02/13/19
NO CHANGE
Target $58
JPMS
Overweight
Activision Blizzard longer term outlook remains favorable, says JPMorgan
JPMorgan analyst Alexia Quadrani lowered her price target for Activision Blizzard to $58 from $63 and keeps an Overweight rating on the shares following the company's Q4 results. The stock may be range bound for the near term given a lack of catalysts and limited view into how in-game services are trending for Call of Duty, Hearthstone, and Overwatch, Quadrani tells investors in a research note. However, her overall thesis though remains unchanged as she remains confident that investors will shift their focus throughout 2019 to the long-term fundamentals supporting the sector, and the 2020 outlook, which is "very likely to include a World of Warcraft expansion and full year of Diablo Immortal." Further, Activision remains a stock with "significant long-term optionality not built into consensus estimates," says Quadrani. The analyst views Activision Blizzard's long-term outlook as favorable.

TODAY'S FREE FLY STORIES

HON

Honeywell

$153.66

0.39 (0.25%)

10:43
02/20/19
02/20
10:43
02/20/19
10:43
Hot Stocks
Breaking Hot Stocks news story on Honeywell »

Honeywell says UOP will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 29

    Apr

HON

Honeywell

$153.66

0.39 (0.25%)

10:41
02/20/19
02/20
10:41
02/20/19
10:41
Hot Stocks
Honeywell says UOP has been 'very disciplined' on the cost side »

Says Honeywell UOP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 29

    Apr

FITB

Fifth Third

$27.49

-0.025 (-0.09%)

10:40
02/20/19
02/20
10:40
02/20/19
10:40
Options
Bearish option flow in Fifth Third Bancorp »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 12

    Mar

10:40
02/20/19
02/20
10:40
02/20/19
10:40
General news
Money market rates have dipped »

Money market rates have…

10:35
02/20/19
02/20
10:35
02/20/19
10:35
Conference/Events
Morgan Stanley sports/footwear analyst to hold analyst/industry conference call »

Sports & Footwear…

KO

Coca-Cola

$44.99

0.17 (0.38%)

10:30
02/20/19
02/20
10:30
02/20/19
10:30
Options
Vote of confidence in Coca Cola »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

ARW

Arrow Electronics

$81.74

0.73 (0.90%)

10:28
02/20/19
02/20
10:28
02/20/19
10:28
Hot Stocks
Arrow Electronics CEO sells over $4.3M worth of shares »

Arrow Electronics CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
Credit Suisse analysts to hold an analyst/industry conference call »

Analysts discuss the HOLT…

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

FLR

Fluor

$37.46

0.46 (1.24%)

, HAL

Halliburton

$32.29

0.59 (1.86%)

10:21
02/20/19
02/20
10:21
02/20/19
10:21
Hot Stocks
Fluor awarded Halliburton chemicals project in Saudi Arabia »

Fluor (FLR) announced…

FLR

Fluor

$37.46

0.46 (1.24%)

HAL

Halliburton

$32.29

0.59 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 15

    May

  • 22

    May

  • 28

    May

W

Wayfair

$120.90

0.67 (0.56%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Hot Stocks
Hedgeye names Wayfair as new short idea »

Hedgeye named Wayfair as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

TSLA

Tesla

$304.20

-1.36 (-0.45%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Options
Put buyers in Tesla weekly options »

Put buyers in Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

IRM

Iron Mountain

$35.51

0.12 (0.34%)

10:18
02/20/19
02/20
10:18
02/20/19
10:18
Recommendations
Iron Mountain analyst commentary  »

Iron Mountain price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
02/20/19
02/20
10:17
02/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$306.68

1.33 (0.44%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Hot Stocks
Humana, PatientPing announce agreement to improve care coordination »

PatientPing announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 19

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

, VEEV

Veeva

$120.49

0.1 (0.08%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

VEEV

Veeva

$120.49

0.1 (0.08%)

AGIO

Agios Pharmaceuticals

$58.78

1.07 (1.85%)

KIDS

OrthoPediatrics

$38.69

1.31 (3.50%)

FIXX

Homology Medicines

$24.90

0.87 (3.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 13

    Mar

  • 26

    Mar

  • 27

    Mar

  • 10

    Apr

  • 11

    Apr

  • 21

    Jun

CVS

CVS Health

$63.82

-6.1 (-8.72%)

, LUV

Southwest

$54.63

-3.03 (-5.25%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CVS

CVS Health

$63.82

-6.1 (-8.72%)

LUV

Southwest

$54.63

-3.03 (-5.25%)

SCHW

Charles Schwab

$45.95

-1.11 (-2.36%)

ETFC

E-Trade

$48.05

-0.61 (-1.25%)

PANW

Palo Alto Networks

$228.77

-1.42 (-0.62%)

TEVA

Teva

$17.40

-0.61 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 04

    Mar

  • 05

    Mar

  • 12

    Mar

IPSEY

Ipsen

$0.00

(0.00%)

, CS

Credit Suisse

$11.91

0.005 (0.04%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

IPSEY

Ipsen

$0.00

(0.00%)

CS

Credit Suisse

$11.91

0.005 (0.04%)

AXL

American Axle

$16.92

0.32 (1.93%)

DO

Diamond Offshore

$10.65

0.36 (3.50%)

RIG

Transocean

$8.86

0.12 (1.37%)

PFE

Pfizer

$42.25

-0.33 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    May

  • 22

    May

LUV

Southwest

$54.67

-2.99 (-5.19%)

, ALK

Alaska Air

$63.60

-0.95 (-1.47%)

10:15
02/20/19
02/20
10:15
02/20/19
10:15
On The Fly
Goldman Sachs says sell Southwest as airline cuts guidance »

Shares of Southwest (LUV)…

LUV

Southwest

$54.67

-2.99 (-5.19%)

ALK

Alaska Air

$63.60

-0.95 (-1.47%)

AAL

American Airlines

$34.96

-0.5 (-1.41%)

UAL

United Continental

$87.68

-1.53 (-1.72%)

DAL

Delta Air Lines

$50.89

-0.93 (-1.79%)

JBLU

JetBlue

$17.68

-0.24 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 04

    Mar

10:15
02/20/19
02/20
10:15
02/20/19
10:15
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

DWDP

DowDuPont

$55.00

0.4 (0.73%)

10:10
02/20/19
02/20
10:10
02/20/19
10:10
Options
Put buyers in DowDuPont weekly options »

Put buyers in DowDuPont…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 04

    Mar

  • 04

    Mar

  • 13

    Mar

  • 28

    May

MGNX

MacroGenics

$21.98

-0.2 (-0.90%)

, XNCR

Xencor

$33.00

-3.18 (-8.79%)

10:09
02/20/19
02/20
10:09
02/20/19
10:09
Recommendations
MacroGenics, Xencor analyst commentary  »

Xencor hold supports…

MGNX

MacroGenics

$21.98

-0.2 (-0.90%)

XNCR

Xencor

$33.00

-3.18 (-8.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

MBIO

Mustang Bio

$4.15

(0.00%)

, FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

10:05
02/20/19
02/20
10:05
02/20/19
10:05
Recommendations
Mustang Bio, Fortress Biotech analyst commentary  »

Mustang Bio partnership…

MBIO

Mustang Bio

$4.15

(0.00%)

FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMB

Trimble

$39.47

0.1 (0.25%)

, DGII

Digi International

$13.40

0.04 (0.30%)

10:03
02/20/19
02/20
10:03
02/20/19
10:03
Hot Stocks
Trimble, Digi collaborate to provide fleets with cold chain compliance solution »

Trimble (TRMB) announced…

TRMB

Trimble

$39.47

0.1 (0.25%)

DGII

Digi International

$13.40

0.04 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 05

    Mar

  • 14

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.